Your browser doesn't support javascript.
loading
Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial.
Vanni, Tazio; Thomé, Beatriz C; Sparrow, Erin; Friede, Martin; Fox, Christopher B; Beckmann, Anna Marie; Huynh, Chuong; Mondini, Gabriella; Silveira, Daniela H; Viscondi, Juliana Y K; Braga, Patrícia Emilia; Silva, Anderson da; Salomão, Maria da Graça; Piorelli, Roberta O; Santos, Joane P; Gattás, Vera Lúcia; Lucchesi, Maria Beatriz B; Oliveira, Mayra M M de; Koike, Marcelo E; Kallas, Esper G; Campos, Lucia M A; Coelho, Eduardo B; Siqueira, Marilda A M; Garcia, Cristiana C; Miranda, Milene Dias; Paiva, Terezinha M; Timenetsky, Maria do Carmo S T; Adami, Eduardo A; Akamatsu, Milena A; Ho, Paulo Lee; Precioso, Alexander R.
Afiliación
  • Vanni T; Instituto Butantan, São Paulo, Brazil.
  • Thomé BC; Instituto Butantan, São Paulo, Brazil.
  • Sparrow E; World Health Organization, Geneva, Switzerland.
  • Friede M; World Health Organization, Geneva, Switzerland.
  • Fox CB; Infectious Disease Research Institute, Seattle, WA, United States of America.
  • Beckmann AM; Infectious Disease Research Institute, Seattle, WA, United States of America.
  • Huynh C; Biomedical Advanced Research and Development Authority, Washington, DC, United States of America.
  • Mondini G; Instituto Butantan, São Paulo, Brazil.
  • Silveira DH; Instituto Butantan, São Paulo, Brazil.
  • Viscondi JYK; Instituto Butantan, São Paulo, Brazil.
  • Braga PE; Instituto Butantan, São Paulo, Brazil.
  • Silva AD; Instituto Butantan, São Paulo, Brazil.
  • Salomão MDG; Instituto Butantan, São Paulo, Brazil.
  • Piorelli RO; Instituto Butantan, São Paulo, Brazil.
  • Santos JP; Instituto Butantan, São Paulo, Brazil.
  • Gattás VL; Instituto Butantan, São Paulo, Brazil.
  • Lucchesi MBB; Instituto Butantan, São Paulo, Brazil.
  • Oliveira MMM; Instituto Butantan, São Paulo, Brazil.
  • Koike ME; Instituto Butantan, São Paulo, Brazil.
  • Kallas EG; Clinics Hospital of the School of Medicine of University of São Paulo, São Paulo, Brazil.
  • Campos LMA; Child Institute of the Clinics Hospital of the School of Medicine of University of São Paulo, São Paulo, Brazil.
  • Coelho EB; Clinics Hospital of the Medical School of Ribeirão Preto of the University of São Paulo, Ribeirão Preto, Brazil.
  • Siqueira MAM; Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Garcia CC; Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Miranda MD; Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
  • Paiva TM; Adolfo Lutz Institute, São Paulo, Brazil.
  • Timenetsky MDCST; Adolfo Lutz Institute, São Paulo, Brazil.
  • Adami EA; Instituto Butantan, São Paulo, Brazil.
  • Akamatsu MA; Instituto Butantan, São Paulo, Brazil.
  • Ho PL; Instituto Butantan, São Paulo, Brazil.
  • Precioso AR; Instituto Butantan, São Paulo, Brazil.
PLoS One ; 17(10): e0274943, 2022.
Article en En | MEDLINE | ID: mdl-36256646
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana / Subtipo H7N9 del Virus de la Influenza A Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Gripe Humana / Subtipo H7N9 del Virus de la Influenza A Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: Estados Unidos